The first human trial of a vaccine to protect against pandemic coronavirus is starting in the US later on Monday, according to reports.
A group of 45 healthy volunteers will have the jab, at the Kaiser Permanente research facility, in Seattle.
The vaccine cannot cause Covid-19 but contains a harmless genetic code copied from the virus that causes the disease.
Experts say it will still take many months to know if this vaccine, or others also in research, will work.
Scientists around the world are fast-tracking research.
And this first human trial, funded by the National Institutes of Health, sidesteps a check that would normally be conducted - making sure the vaccine can trigger an immune response in animals.
But the biotechnology company behind the work, Moderna Therapeutics, says the vaccine has been made using a tried and tested process.
Dr John Tregoning, an expert in infectious diseases at Imperial College London, UK, said: "This vaccine uses pre-existing technology.
"It's been made to a very high standard, using things that we know are safe to use in people and those taking part in the trial will be very closely monitored.
"Yes, this is very fast - but it is a race against the virus, not against each other as scientists, and it's being done for the benefit of humanity."
Typical vaccines for viruses, such as measles, are made from a weakened or killed virus.
But the mRNA-1273 vaccine is not made from the virus that causes Covid-19.
Instead, it includes a short segment of genetic code copied from the virus that scientists have been able to make in a laboratory.
This will hopefully prime the body's own immune system to fight off the real infection.
The volunteers will be given different doses of the experimental vaccine.
They will each be given two jabs in total, 28 days apart, into the upper arm muscle.
But even if these initial safety tests go well, it could still take up to 18 months for any potential vaccine to become available for the public.
Latest Stories
-
T-bills: Interest rates increased for first time since January 1; government fails to meet target
1 hour -
Ghana retains 10th position with lowest fuel price in Africa
1 hour -
Will Ghana’s democracy stand the test of time in the 2024 elections?
4 hours -
Hindsight: Dreams fairytale run proved one thing; it is possible
6 hours -
God makes rulers, not you; you can’t choose your successor – Mahama to Akufo-Addo
6 hours -
Contributors own SSNIT, they must decide who becomes its Director-General – Austin Gamey
7 hours -
Move away from theory-based learning towards practical learning approaches – AUCC President to students
7 hours -
Haaland scores as Manchester City beat Nottingham Forest
9 hours -
Villas-Boas elected Porto president
9 hours -
Situation on frontline has worsened, Ukraine army chief says
9 hours -
US doctor describes witnessing starvation in northern Gaza
9 hours -
CAFCC: RS Berkane make final after USM Alger refused to play 2nd leg over Moroccans’ jersey
9 hours -
Elon Musk in China to discuss enabling full self driving
9 hours -
PSG clinch Ligue 1 title after Lyon’s win over Monaco
11 hours -
Guinness Ghana sets the pace at Ghana Beverage Awards with six awards
12 hours